Healthcare
ZBIO
Zenas BioPharma, Inc.
About Zenas BioPharma, Inc.
Zenas BioPharma is a drug development company working on treatments for autoimmune diseases, which are conditions where the immune system mistakenly attacks the body's own tissues. The company is testing several experimental medicines, with its main focus on obexelimab, a drug designed to treat diseases like lupus and multiple sclerosis. These medicines are still in clinical testing stages and have not yet been approved for patient use. The company was founded in 2019 and is based in Massachusetts.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore